WindRose Health Investors (WindRose) has completed the recapitalisation of RevHealth, a science-focused independent provider of omnichannel healthcare communications. Terms of the transaction have not been disclosed.
WindRose, a New York-based healthcare private equity firm, is partnering with RevHealth’s founders to recapitalise the business and provide additional capital to support future growth. With WindRose’s investment, RevHealth is well-positioned to further accelerate its impressive growth, drawing on WindRose’s extensive experience investing in innovative pharmaceutical services companies. Bruce Epstein, Bruce Medd, and Brian Wheeler, RevHealth’s founders, will continue to lead the company and remain significant shareholders.
Guggenheim Securities, LLC acted as the exclusive financial advisor to WindRose and Houlihan Lokey acted as the exclusive financial advisor to RevHealth. McDermott Will & Emery LLP acted as legal advisor to WindRose and DLA Piper LLP acted as legal advisor to RevHealth.
